Owner Mitsubishi Chemical Team condemns decision on ‘considerable adjustments’ to injection market
Mitsubishi Chemical Group is closing down Medicago Inc., a COVID-19 injection maker with headquarters in Quebec City.
A year earlier, Medicago’s plant-based COVID-19 vaccine, Covifenz, was authorized by Health Canada, and also it was proclaimed as a domestic shot versus SARS-CoV-2.
After that in March, the World Wellness Company made a decision not to accept Medicago’s COVID-19 vaccination for emergency usage, mentioning the company’s ties to huge cigarette. Marlboro cigarette supplier Philip Morris International was once a shareholder of Medicago, however unloaded all of its shares in late 2022.
Medicago Inc., which was started in 1997, is currently 100 per cent owned by Mitsubishi Tanabe Pharma Corporation.
On Thursday, Medicago owner Mitsubishi Chemical Group released a declaration stating there have been “significant changes” to the vaccine market and also, adhering to a comprehensive evaluation of the current international need, the team chose to cease advertising Covifenz.
” Moreover, the team evaluated that it was not viable to continue to purchase the commercialization of Medicago’s advancement items and as a result selected to terminate all its activities with Medicago and also wage an organized dissolution of its service affairs and tasks,” the statement said.
According to the declaration, Medicago’s business tasks and routine operating tasks will certainly be substantially lowered as well as redoubled during the liquidation procedure.
” Dissolution procedures will occur eventually in accordance with regional legislations as well as regulations,” it stated.
Government invested $173M in Medicago
Canada’s federal government spent $173 million into the firm in 2020 to assist the company develop the vaccine and its Quebec manufacturing facility. Ottawa also authorized a deal to buy 20 million doses of the vaccine, with an alternative for 56 million more.
The process created by Medicago uses the plant species nicotiana benthamiana, a close relative of cigarette plants that is made use of for pharmaceutical growth mainly because of the high number of viruses that can efficiently contaminate it.
When it was approved, research studies of Covifenz found the two-dose shot’s overall efficiency price versus all infection variants studied was 71 percent, with a greater efficacy price of 75 per cent against COVID-19 infections from the delta variant.
At the time, Wellness Canada stated that “initial and exploratory data shows that Covifenz generates neutralizing antibodies against the Omicron version.”
On Twitter Thursday, Quebec City Mayor Bruno Marchand called the Medicago closure a “huge pity.”
” My ideas are with the family members who found out some really unfortunate information today,” he said. “We have to roll up our sleeves to maintain all this knowledge in the area of health and wellness development in Quebec.”
Last Updated: 03 February 2023